IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sigilon Therapeutics Inc

CUSIP: 82657L206 | 19 institutional holders

Quarters

Q3 2023Q2 2023
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2023

IFP Advisors, Inc200
0.0% of portfolio›$4.5K
StyleTurnoverLocationFiled
IFP Advisors, Inc
200$4.5K0.0%GrowthLowTampa, FL2023-10-12